ICD-10-CM Billable Code

T45.7X3

Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault

Clinical Classification Guidelines

Medical Intelligence & Overview

Poisoning by anticoagulant antagonists, including vitamin K and other coagulants, occurs when an individual is exposed to substances that interfere with blood clotting. This form of poisoning is classified under ICD-10 code T45.7X3 and typically results from misuse, overdose, or accidental exposure to drugs designed to thin blood. While anticoagulants are crucial in preventing blood clots, improper use or overdose can lead to serious bleeding complications. Understanding the causes, symptoms, diagnosis, and treatment options is vital for managing this condition effectively.

Causes & Symptoms

Clinical Causes: Accidental ingestion of anticoagulant medications, especially in children. Intentional overdose of anticoagulant drugs for self-harm or suicidal attempts. Misuse of anticoagulants due to incorrect dosing or lack of medical supervision. Exposure to contaminated or improperly stored anticoagulant products. Interactions with other medications that enhance the effects of anticoagulants, leading to excessive bleeding risk. Lack of proper awareness about the potency and risks associated with anticoagulant drugs.

Key Symptoms: Unusual or excessive bleeding, including from gums, nosebleeds, or easy bruising. Blood in urine or stool, which may appear dark or tarry. Unexplained fatigue or weakness caused by blood loss. Dizziness or lightheadedness, especially if bleeding is significant. Severe cases may result in internal bleeding, signs of shock, or neurological symptoms due to bleeding in the brain. In some cases, there may be no symptoms until significant bleeding occurs.

Diagnostic & Treatment

Diagnosis Path: Diagnosis of poisoning by anticoagulant antagonists involves a combination of medical history assessment, physical examination, and laboratory tests. Blood tests such as prothrombin time (PT) and international normalized ratio (INR) are crucial to evaluate blood clotting capacity. Elevated INR levels indicate a higher risk of bleeding. Additionally, blood tests may measure specific drug levels if available. Healthcare providers may also inquire about recent medication use, possible exposure sources, and any symptom progression to establish an accurate diagnosis and determine the severity of poisoning.

Treatment Protocols: Administration of vitamin K (phytonadione) to counteract the effects of certain anticoagulants, especially in cases of overdose. Use of fresh frozen plasma or prothrombin complex concentrates to provide clotting factors directly and rapidly reduce bleeding risk. Supportive care, including blood transfusions if significant blood loss has occurred. Monitoring of clotting parameters regularly to assess treatment effectiveness. Addressing underlying causes such as medication overdose or accidental ingestion. Patient education on safe medication use and storage to prevent future incidents.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T45.7X3 a billable ICD-10 code?
Yes, T45.7X3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T45.7X3?
Clinical documentation must specify the nature of Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault and any associated comorbidities for accurate reporting.

Cite this Clinical Reference